The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Insurance Subcommittee Responds to Payer Policies

ACR Insurance Subcommittee Responds to Payer Policies

April 26, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR’s Insurance Subcommittee (ISC) of the Committee on Rheumatologic Care reviews payer policies to ensure patient access and fair and consistent provider reimbursement. When the ISC identifies a problematic policy, often via a report from an ACR member, a letter is sent to the payer outlining the ACR’s concerns and requesting corrective action.

You Might Also Like
  • The ACR Insurance Subcommittee Advocates for Fair Payer Policies
  • Insurance Subcommittee Responds to Health Plan Complaints
  • Protect Your Practice: Action Update From the ACR’s Insurance Subcommittee
Also By This Author
  • Coding Corner Question

The ISC has had a busy start to 2018, sending eight letters since the beginning of the year. Several policy trends the ISC has responded to are detailed below. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Reimbursement for E/M Services when Billed with Modifier 25
As reported previously in ACR@Work, Anthem Blue Cross announced—and eventually rescinded—a policy that would have reduced reimbursement for evaluation and management (E/M) services when billed with modifier 25 by up to 50%. While the ACR was part of a successful advocacy effort to overturn the Anthem policy, several other payers have, unfortunately, moved forward with implementation of similar reimbursement cuts. In early April, the ISC sent a second letter to Independence Blue Cross underscoring the ACR’s opposition to its misguided modifier 25 policy and requesting further investigation into related reports of claims processing errors.

Site-of-Service Restrictions for Infused Drugs
Blue Cross Blue Shield of Arizona is the latest plan to implement a site-of-service policy that limits coverage for infusions performed in hospital outpatient facilities. It joins a growing list of payers the ISC has communicated with regarding such restrictions since 2015. Other payers with similar policies include Anthem, Cigna, Humana, Medical Mutual of Ohio, Regence BlueShield and UnitedHealthcare. The ACR’s position on this issue is detailed in the position statement Patient Safety and Site of Service for Biologics.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Formulary Changes & Patient Access Issues
The ISC also recently responded to several policies concerning formulary changes and patient access to specific drugs. As described in the Patient Access to Biologics position statement, the ACR opposes step edits, fail-first policies, tiering, forced switching and excessive coinsurance for biologics. The ISC monitors such formulary changes and restrictions, and regularly dialogues with payers to help preserve patient access.

If you have questions regarding these policies or other insurance concerns, contact practice@rheumatology.org.

Filed Under: From the College, Professional Topics Tagged With: ACR Insurance Subcommittee, ACR Insurance Subcommittee (ISC), Anthem Blue Cross, Blue Cross Blue Shield, Health Insurance

You Might Also Like:
  • The ACR Insurance Subcommittee Advocates for Fair Payer Policies
  • Insurance Subcommittee Responds to Health Plan Complaints
  • Protect Your Practice: Action Update From the ACR’s Insurance Subcommittee
  • Insurance Subcommittee to the Rescue

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.